Concepts (76)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sudden Infant Death | 6 | 2011 | 22 | 1.420 |
Why?
|
| Sodium Channels | 3 | 2010 | 20 | 0.460 |
Why?
|
| Mutation, Missense | 2 | 2011 | 172 | 0.430 |
Why?
|
| Long QT Syndrome | 3 | 2010 | 30 | 0.400 |
Why?
|
| Gap Junctions | 1 | 2011 | 16 | 0.380 |
Why?
|
| Connexin 43 | 1 | 2011 | 13 | 0.380 |
Why?
|
| Channelopathies | 1 | 2008 | 5 | 0.300 |
Why?
|
| Sugar Alcohol Dehydrogenases | 1 | 2007 | 1 | 0.290 |
Why?
|
| Glycerolphosphate Dehydrogenase | 1 | 2007 | 4 | 0.290 |
Why?
|
| Ion Channels | 1 | 2008 | 88 | 0.290 |
Why?
|
| Death, Sudden | 1 | 2007 | 28 | 0.280 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2008 | 145 | 0.270 |
Why?
|
| Infant | 6 | 2011 | 1492 | 0.260 |
Why?
|
| Heart Diseases | 1 | 2008 | 206 | 0.250 |
Why?
|
| Infant, Newborn | 4 | 2009 | 1284 | 0.180 |
Why?
|
| Muscle Proteins | 2 | 2009 | 111 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2011 | 676 | 0.130 |
Why?
|
| Cohort Studies | 3 | 2011 | 2375 | 0.120 |
Why?
|
| Patch-Clamp Techniques | 2 | 2011 | 126 | 0.110 |
Why?
|
| Myocytes, Cardiac | 2 | 2011 | 88 | 0.110 |
Why?
|
| Rats | 3 | 2011 | 1910 | 0.100 |
Why?
|
| Phosphatidylethanolamines | 1 | 2012 | 17 | 0.100 |
Why?
|
| Desmoplakins | 1 | 2011 | 7 | 0.100 |
Why?
|
| Phase Transition | 1 | 2012 | 20 | 0.100 |
Why?
|
| Scattering, Radiation | 1 | 2012 | 72 | 0.100 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 2 | 2009 | 5 | 0.100 |
Why?
|
| Cadherins | 1 | 2011 | 68 | 0.090 |
Why?
|
| Light | 1 | 2012 | 198 | 0.090 |
Why?
|
| DNA Mutational Analysis | 2 | 2009 | 188 | 0.090 |
Why?
|
| Protein Transport | 1 | 2011 | 399 | 0.090 |
Why?
|
| Sodium | 1 | 2009 | 60 | 0.080 |
Why?
|
| Genotype | 2 | 2009 | 617 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 87 | 0.080 |
Why?
|
| Myocardium | 1 | 2009 | 264 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2008 | 185 | 0.070 |
Why?
|
| Male | 5 | 2011 | 27749 | 0.070 |
Why?
|
| Cell Line | 2 | 2009 | 1983 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 495 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 439 | 0.060 |
Why?
|
| Female | 5 | 2011 | 30726 | 0.060 |
Why?
|
| Electrocardiography | 1 | 2008 | 523 | 0.060 |
Why?
|
| Kidney | 1 | 2007 | 414 | 0.060 |
Why?
|
| Humans | 6 | 2011 | 59389 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2009 | 850 | 0.060 |
Why?
|
| Adult | 2 | 2011 | 15681 | 0.050 |
Why?
|
| Mass Screening | 1 | 2008 | 648 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2007 | 1793 | 0.050 |
Why?
|
| Risk Factors | 2 | 2010 | 4986 | 0.050 |
Why?
|
| Mutation | 1 | 2007 | 2456 | 0.040 |
Why?
|
| Animals | 3 | 2011 | 19650 | 0.040 |
Why?
|
| Child | 1 | 2007 | 4189 | 0.040 |
Why?
|
| Adolescent | 1 | 2007 | 5838 | 0.030 |
Why?
|
| Transition Temperature | 1 | 2012 | 5 | 0.020 |
Why?
|
| Middle Aged | 1 | 2007 | 16314 | 0.020 |
Why?
|
| Brugada Syndrome | 1 | 2010 | 1 | 0.020 |
Why?
|
| Voltage-Gated Sodium Channel beta-3 Subunit | 1 | 2010 | 1 | 0.020 |
Why?
|
| Voltage-Gated Sodium Channel beta-4 Subunit | 1 | 2010 | 1 | 0.020 |
Why?
|
| Plasma Membrane Calcium-Transporting ATPases | 1 | 2009 | 1 | 0.020 |
Why?
|
| Kinetics | 1 | 2012 | 751 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2009 | 6 | 0.020 |
Why?
|
| Autopsy | 1 | 2010 | 53 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2009 | 45 | 0.020 |
Why?
|
| Ion Channel Gating | 1 | 2009 | 44 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2009 | 80 | 0.020 |
Why?
|
| Cadaver | 1 | 2010 | 110 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2009 | 137 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 574 | 0.020 |
Why?
|
| Tachycardia, Ventricular | 1 | 2010 | 119 | 0.020 |
Why?
|
| Transfection | 1 | 2009 | 675 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 347 | 0.020 |
Why?
|
| Prevalence | 1 | 2010 | 1253 | 0.020 |
Why?
|
| Phenotype | 1 | 2009 | 1137 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2010 | 1925 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 3617 | 0.010 |
Why?
|
| United States | 1 | 2010 | 7426 | 0.010 |
Why?
|
| Mice | 1 | 2009 | 10291 | 0.010 |
Why?
|